The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

WALL STREET DOES NOT APPRECIATE TRANSFORMATION OF CIENA $CIEN

November 3, 2010

Our analysis indicates acquisition of Nortel’s business is working out for CIEN. As investors realize the reality, large number of shorts will be squeezed possibly doubling the stock. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

WE HAVE BEEN PROVEN RIGHT ON AMPYRA FROM ACORDA THERAPEUTICS

November 1, 2010

Today Acorda Therapeutics (ACOR) reported earnings. Acorda stock has risen on hopes for blockbuster sales of its MS walking drug Ampyra. First the stock went higher,  but started falling when investors realized that sales will drop next quarter. Our negative stance on Ampyra sales has proven right. Earlier in the year, when  Wall Street was unanimously wildly bullish on Acorda, we wrote the following: In the short term, the bulls may be right. For the first time, MS patients with difficulty in walking have hope. MS patients, in general tend to be very knowledgeable about new drugs and as such they

Read More »

NEW RARE EARTH METALS ETF $REMX SENDS MOLYCORP $MCP AND RARE EARTH ELEMENTS $REE INTO RAREFIED TERRITORY

October 27, 2010

In anticipation of tomorrow’s launch of a Rare Earth ETF by Van Eck under the ticker symbol “REMX” Molycorp and Rare Earth Elements have strongly moved up. We will continue to take advantage of this up move by trading these two stocks in a manner described in the prior post to take advantage of intraday volatility. If the stocks go much higher, we will continue to scale in our core short positions. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since

Read More »

PER THE PRIOR POST ADDING $MCP AROUND $39.20 AND $REE AROUND $12.80

October 27, 2010

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

ADDING TO OUR SHORT POSITIONS ON MOLYCORP $MCP RIGHT HERE AROUND $34.70.AND RARE ELEMENT RESOURCES $REE AT $11.72

October 19, 2010

Image via Wikipedia One simply needs to look at the float and the volume traded today to understand that the move up in $MCP and $REE is massive short squeeze. The trigger for today’s move up is the report that China may ban export of rare earth elements to Europe and US. There are several misconceptions in the market. First, for the most part the name rare earth elements is a misnomer. Most of these elements exist in abundance. Second, there is a misconception that these elements are available only in China. Nothing could be farther from the truth. Due

Read More »

ADDING TO OUR SHORT POSITIONS ON MOLYCORP $MCP RIGHT HERE AT $33.10 AND RARE ELEMENT RESOURCES $REE AT $10.72

October 19, 2010

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of winning positions: 162 Number of losing positions: 10 Average annualized % return per position: 296.77% ………………Check out details .

Read More »

STEVE JOB’S COMMENTS ON APPLE $AAPL CONFERENCE CALL IS A TRIGGER TO SHORT SELL RESEARCH IN MOTION $RIMM

October 18, 2010

On Apple’s conference call Steve Job stated that over 80% of Fortune 500 companies are running pilots for ultimate enterprise wide deployment of iPhone. This number is much higher than the expectations. $RIMM has been on our list to short and now we have the trigger event as required by our ZYX Change Method. IN after hours , we scaled in a short on $RIMM  at $48.16.  We will add to the short  position on up spikes .  There is no immediate danger of Blackberry losing market share, it will be a slow process. Therefore, we will not overstay our

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content